ArticleNature communications2026
Stabilizing 1.93-eV ultrawide-bandgap perovskites for efficient triple-junction solar cells.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Monolithic perovskite/perovskite/silicon triple-junction solar cells offer higher theoretical efficiency than their two-junction counterparts. However, the phase instability of ultrawide-bandgap perovskites remains a major obstacle to further improve the efficiency and stability of triple-junction devices. Here, we introduce 1,4-phenylenediamine dihydriodide into the 1.93-eV bandgap perovskite, which significantly increases the ion migration barrier and suppresses phase segregation through strong interactions with the perovskite lattice. Combined with a post-treatment using 3-(methylthio)propylamine hydroiodide to modify the perovskite surface, we achieved a certified efficiency of 26.18% for the triple-junction solar cell, with an impressive open-circuit voltage of 3.148 V on an aperture area of 1.17 cm². Notably, the encapsulated devices retained 96% of their initial performance after 1500 hours of continuous maximum power point tracking under one-sun illumination in ambient conditions, representing the notable stability in perovskite/perovskite/silicon triple-junction cells reported to date.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.